Octagon Capital is a New York-based merchant banking and direct investing firm focused on small-cap, mid-cap and private companies with value-creation potential. The firm provides capital and advisory support and makes direct investments in select situations, with U.S. activity spanning early- and later-stage private financings. Its investment exposure includes biotechnology, life sciences, pharmaceuticals and oncology, alongside healthcare, technology, consumer, media and telecommunications.